Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment With Zoledronic Acid Subsequent to Denosumab in Osteoporosis

NCT03087851 is registered in ClinicalTrials.gov with Aarhus University Hospital as lead sponsor.

NCT NCT03087851
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03087851 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment With Zoledronic Acid Subsequent to Denosumab in Osteoporosis
Lead sponsor
Aarhus University Hospital
Phase
Phase 4
Overall status
Completed
Start date
March 13, 2017
Completion date
August 1, 2020
Enrollment
61 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis